Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers

INTRODUCTION: There is an urgent need to identify biomarkers that can accurately detect and diagnose Alzheimer's disease (AD). Autoantibodies are abundant and ubiquitous in human sera and have been previously demonstrated as disease-specific biomarkers capable of accurately diagnosing mild-mode...

Descripción completa

Detalles Bibliográficos
Autores principales: DeMarshall, Cassandra A., Nagele, Eric P., Sarkar, Abhirup, Acharya, Nimish K., Godsey, George, Goldwaser, Eric L., Kosciuk, Mary, Thayasivam, Umashanger, Han, Min, Belinka, Benjamin, Nagele, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879649/
https://www.ncbi.nlm.nih.gov/pubmed/27239548
http://dx.doi.org/10.1016/j.dadm.2016.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879649/
https://www.ncbi.nlm.nih.gov/pubmed/27239548
http://dx.doi.org/10.1016/j.dadm.2016.03.002

Ejemplares similares